2528
K. Yaji, M. Shindo
LETTER
(14) Representative Experimental Procedure for the
(9) Recent examples by West: (a) Rieder, C. J.; Fradette, R. J.;
West, F. G. Chem. Commun. 2008, 1572. (b) Grant, T. G.;
West, F. G. Org. Lett. 2007, 9, 3789. (c) Mahmoud, B.;
West, F. G. Tetrahedron Lett. 2007, 48, 2091. (d) Rostami,
A.; Wang, Y.; Arif, A. M.; McDonald, R.; West, F. G. Org.
Lett. 2007, 9, 703. (e) Grant, T. N.; West, F. G. J. Am. Chem.
Soc. 2006, 128, 9348. (f) Giese, S.; Mazzola, R. D. Jr.;
Amann, C. M.; Arif, A. M.; West, F. G. Angew. Chem. Int.
Ed. 2005, 44, 6546. (g) White, T. D.; West, F. G.
Tetrahedron Lett. 2005, 46, 5629. (h) Browder, C. C.;
Marmsäter, F. P.; West, F. G. Can. J. Chem. 2004, 82, 375.
(10) (a) Basak, A. K.; Tius, M. A. Org. Lett. 2008, 10, 4073.
(b) For a chiral auxiliary-controlled interrupted Nazarov
reaction, see: Dhoro, F.; Kristensen, T. E.; Stockmann, V.;
Yap, G. P. A.; Tius, M. A. J. Am. Chem. Soc. 2007, 129,
7256. (c) Dhoro, F.; Tius, M. A. J. Am. Chem. Soc. 2005,
127, 12472.
(11) (a) Nishiyama, H.; Sakaguchi, H.; Nakamura, T.; Horihata,
M.; Kondo, M.; Itoh, K. Organometallics 1989, 8, 846.
(b) Nishiyama, H.; Itoh, K. J. Synth. Org. Chem. Jpn. 1995,
53, 500. (c) Nishiyama, H. Enantiomer 1999, 4, 569.
(12) For recent reviews on pybox ligands, see: Desimoni, G.;
Faita, G.; Quadrelli, P. Chem. Rev. 2003, 103, 3119.
(13) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am.
Chem. Soc. 1991, 113, 4092.
Catalytic Asymmetric Nazarov Reaction
A solution of Sc(OTf)3 (9.8 mg, 0.02 mmol), pybox–Ph (8,
8.1 mg, 0.022 mmol) in dry CH2Cl2 (0.4 mL) was stirred for
3 h. Then, Et3N (2.0 mL, 0.014 mmol) and the (E)-b-alkoxy
divinyl ketone (23, 54 mg, 0.2 mmol) in dry CH2Cl2 (0.4
mL) were added. The mixture was stirred at r.t. for 4 h,
quenched with sat. aq NaHCO3, and extracted with CH2Cl2.
The organic extract was washed with sat. aq NaHCO3 and
brine, dried over MgSO4, filtered, and concentrated in
vacuo. The residual oil was purified over silica gel column
chromatography (hexane–EtOAc, 80:20) to afford the
a-alkoxy cyclopentenone (20).
Compound 20 [R1 = Ph(CH2)2, R2 = i-Pr]: 1H NMR (600
MHz, CDCl3): d = 1.07 (d, J = 6.6 Hz, 3 H), 1.10 (d, J = 6.0
Hz, 3 H), 1.26 (s, 3 H), 1.57 (s, 3 H), 2.40 (d, J = 18.0 Hz, 1
H), 2.64–2.78 (m, 3 H), 2.85 (t, J = 7.2 Hz, 2 H), 3.66 (quint,
J = 6.0 Hz, 1 H), 7.16–7.29 (m, 5 H). 13C NMR (150 MHz,
CDCl3): d = 7.89, 23.2, 24.2, 24.7, 32.6, 33.0, 44.0, 66.8,
78.7, 126.4, 128.2, 128.5, 134.6, 140.3, 168.8, 208.5. IR
(neat): 1706, 1643, 1082 cm–1. MS (EI): m/z = 229 [M+ –
CH(CH3)2]. HRMS–FAB: m/z calcd for C18H25O2 [M+ + H]:
273.1856; found: 273.1855. [a]D –6.7 (c 0.3, CHCl3, 80%
ee). The enantiomeric purity of 20 [R1 = Ph(CH2)2, R2 =
i-Pr] was determined by HPLC analysis [Chiralpak OJ-H,
hexane–i-PrOH (90:10), 1.0 mL/min, 254 nm] in
comparison with authentic racemic material.
Synlett 2009, No. 15, 2524–2528 © Thieme Stuttgart · New York